遇见数据集

Dataset related to the article "Why Levosimendan Improves the Clinical Condition of Patients With Advanced Heart Failure: A Holistic Approach"

收藏
Zenodo2022-01-13 更新2026-05-25 收录
数据链接:
官方服务:

资源简介:

<strong>Background: </strong>In advanced heart failure (HF), levosimendan increases peak oxygen uptake (VO<sub>2</sub>). We investigated whether peak VO<sub>2</sub> increase is linked to cardiovascular, respiratory, or muscular performance changes. <strong>Methods and results: </strong>Twenty patients hospitalized for advanced HF underwent, before and shortly after levosimendan infusion, 2 different cardiopulmonary exercise tests: (a) a personalized ramp protocol with repeated arterial blood gas analysis and standard spirometry including alveolar-capillary gas diffusion measurements at rest and at peak exercise, and (b) a step incremental workload cardiopulmonary exercise testing with continuous near-infrared spectroscopy analysis and cardiac output assessment by bioelectrical impedance analysis.Levosimendan significantly decreased natriuretic peptides, improved peak VO<sub>2</sub> (11.3 [interquartile range 10.1-12.8] to 12.6 [10.2-14.4] mL/kg/min, P &lt; .01) and decreased minute ventilation to carbon dioxide production relationship slope (47.7 ± 10.7 to 43.4 ± 8.1, P &lt; .01). In parallel, spirometry showed only a minor increase in forced expiratory volume, whereas the peak exercise dead space ventilation was unchanged. However, during exercise, a smaller edema formation was observed after levosimendan infusion, as inferable from the changes in diffusion components, that is, the membrane diffusion and capillary volume. The end-tidal pressure of CO<sub>2</sub> during the isocapnic buffering period increased after levosimendan (from 28 ± 3 mm Hg to 31 ± 2 mm Hg, P &lt; .01). During exercise, cardiac output increased in parallel with VO<sub>2</sub>. After levosimendan, the total and oxygenated tissue hemoglobin, but not deoxygenated hemoglobin, increased in all exercise phases. <strong>Conclusions: </strong>In advanced HF, levosimendan increases peak VO<sub>2</sub>, decreases the formation of exercise-induced lung edema, increases ventilation efficiency owing to a decrease of reflex hyperventilation, and increases cardiac output and muscular oxygen delivery and extraction.

提供机构:
Zenodo
创建时间:
2022-01-12
二维码
社区交流群
二维码
科研交流群
商业服务